Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cross-Sectional Study to Determine Distribution of Genetic Variants Among Subjects at Risk of, or With Known Non-alcoholic Steatohepatitis (NASH)

NCT05423327 is registered in ClinicalTrials.gov with Regeneron Pharmaceuticals as lead sponsor.

NCT NCT05423327
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05423327 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cross-Sectional Study to Determine Distribution of Genetic Variants Among Subjects at Risk of, or With Known Non-alcoholic Steatohepatitis (NASH)
Lead sponsor
Regeneron Pharmaceuticals
Phase
Not applicable
Overall status
Terminated
Start date
December 9, 2021
Completion date
October 27, 2022
Enrollment
5,311 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic steatohepatitis (nash)